$3.58 Billion is the total value of Slate Path Capital LP's 18 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 800.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRcall | $1,781,052,000 | – | 9,100,000 | +100.0% | 49.78% | – |
| SPY | New | SPDR S&P 500 ETF TRput | $362,082,000 | – | 1,850,000 | +100.0% | 10.12% | – |
| QQQ | New | POWERSHARES QQQ TRUSTput | $234,775,000 | – | 2,500,000 | +100.0% | 6.56% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $129,305,000 | – | 314,000 | +100.0% | 3.61% | – |
| ALLE | New | ALLEGION PUB LTD CO | $93,522,000 | – | 1,650,000 | +100.0% | 2.61% | – |
| YOKU | New | YOUKU TUDOU INCsponsored adr | $52,611,000 | – | 2,205,000 | +100.0% | 1.47% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $37,776,000 | +36.7% | 598,000 | +45.3% | 1.06% | -49.5% |
| QCOR | New | QUESTCOR PHARMACEUTICALS INCput | $34,221,000 | – | 370,000 | +100.0% | 0.96% | – |
| CLF | New | CLIFFS NAT RES INC | $12,868,000 | – | 855,000 | +100.0% | 0.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
| SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.